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Vacuolar iron transporters (VITs) are a poorly understood family of integral membrane proteins that 
can function in iron homeostasis via sequestration of labile Fe2+ into vacuolar compartments. Here 
we report on the heterologous overexpression and purification of PfVIT, a vacuolar iron transporter 
homologue from the human malaria-causing parasite Plasmodium falciparum. Use of synthetic, codon-
optimised DNA enabled overexpression of functional PfVIT in the inner membrane of Escherichia coli 
which, in turn, conferred iron tolerance to the bacterial cells. Cells that expressed PfVIT had decreased 
levels of total cellular iron compared with cells that did not express the protein. Qualitative transport 
assays performed on inverted vesicles enriched with PfVIT revealed that the transporter catalysed 
Fe2+/H+ exchange driven by the proton electrochemical gradient. Furthermore, the PfVIT transport 
function in this system did not require the presence of any Plasmodium-specific factor such as post-
translational phosphorylation. PfVIT purified as a monomer and, as measured by intrinsic protein 
fluorescence quenching, bound Fe2+ in detergent solution with low micromolar affinity. This study of 
PfVIT provides material for future detailed biochemical, biophysical and structural studies to advance 
understanding of the vacuolar iron transporter family of membrane proteins from important human 
pathogens.
Malaria is a serious parasitic disease, caused by unicellular protozoa of the genus Plasmodium, which is responsi-
ble for high morbidity and mortality rates among those infected. In 2013 alone the most virulent human malaria 
parasite, P. falciparum, was responsible for an estimated 198 million clinical cases of infection and more than 0.5 
million deaths1. Emerging resistance against the therapies commonly used to control malaria infection means 
there is acute need to identify new therapeutic targets in the parasite2,3. In view of the importance of iron metabo-
lism to survival of plasmodial cells, especially during the intraerythrocytic stage of the life cycle, membrane trans-
porter proteins that function in iron homeostasis in the parasite could represent attractive novel drug targets3.
Iron is an essential micronutrient for almost all organisms and is a constituent of biological macromolecules 
involved in critical cellular processes such as energy production, respiration and DNA synthesis4,5. However, the 
same redox properties of iron that have been exploited for beneficial purposes also make it potentially cytotoxic; 
oxidation of excess ferrous iron (Fe2+) to the ferric state (Fe3+) by the Fenton reaction in the cell cytoplasm results 
in production of reactive free hydroxyl radicals that cause oxidative damage to nucleic acids, lipids and proteins6. 
To prevent such damage but at the same time ensure adequate supply of essential iron, cells have evolved inte-
grated mechanisms for maintenance of iron homeostasis via tight and coordinated regulation of the systems 
that control iron provision and storage4. A major role in this regulatory process is played by integral membrane 
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proteins that function in transport of ferrous iron7,8. One group of transporters involved in this process is the vac-
uolar iron transporter (VIT) family (Transporter Classification Database #2.A.89; www.tcdb.org), poorly under-
stood proteins that function in secondary active transport of Fe2+(and also Mn2+ and, in some cases, Zn2+) across 
membranes, probably via a proton-driven antiport mechanism9. Although VIT family proteins have been studied 
mainly in plants10–12 and yeast13, homologues have also been identified in other eukaryotes (but not animals) and 
in bacteria and archaea14. VIT proteins are single polypeptides of between 250–400 amino acids organised into 5 
putative transmembrane spanning α -helices (TMHs) and with an extended, hydrophilic N-terminal tail. In plant 
representatives of the VIT family the TMHs have a 2+ 2+ 1 arrangement, whereas bacterial and archaeal VIT 
homologues may have them in a 1+ 2+ 2 or 2+ 3 arrangement9 (Supplementary Fig. S1).
Bioinformatics studies performed by Martin et al.15,16 suggested a 273 amino acid, ~31 kDa VIT family homo-
logue termed PfVIT (PlasmoDB ID: PF3D7_1223700; Supplementary Fig. S2a) was localised to the digestive 
vacuole (DV) membrane of P. falciparum from where it transports ferrous iron into the acidic vacuole interior 
via an antiport reaction. Although more recent experimental work by Slavic et al.17 implied that PfVIT is actu-
ally localised to the endoplasmic reticulum (ER) membrane of Plasmodium, it could not be established whether 
PfVIT functioned as an exchanger or facilitative transporter of Fe2+. To enable study of the transport mecha-
nism of the protein, we exploited synthetic, codon-optimised DNA for the heterologous high-level expression 
of recombinant PfVIT in Escherichia coli, followed by purification of the recombinant transporter. Our results 
demonstrate that heterologous overexpression of PfVIT in E. coli confers increased resistance to iron-mediated 
cell death to the bacterial cells and that the PfVIT transport mechanism is Fe2+/H+ antiport driven by the proton 
electrochemical gradient.
Results
Heterologous expression of PfVIT using synthetic gene technology. Initial attempts to heterol-
ogously express full length P. falciparum VIT homologue, PfVIT, in several different expression strains of E. 
coli (including those that co-expressed tRNAs for E. coli rare codons) from pET or pBAD/Myc-His vectors that 
contained the native PfVIT coding sequence were unsuccessful. We therefore ligated a synthetic protein cod-
ing sequence that was optimised for heterologous expression in E. coli (Supplementary Fig. S3) into a modified 
pBAD/Myc-His A vector, transformed the resultant plasmid into E. coli LMG194, and tested the efficacy of this 
system for production of the target protein. A range of expression conditions were tested, including the effects 
of altering parameters such as growth temperature, L-arabinose inducer concentration, and time and length of 
induction on production of target protein. Western blot detection of the hexahistidine affinity tag of the protein 
construct in dodecyl-β -D-maltopyranoside (DDM)-detergent solubilised membrane fractions was used to deter-
mine conditions for successful overproduction. Although many of the conditions tested revealed heterologous 
expression of PfVIT, another band was also visible on western blots. Only one set of conditions resulted in exclu-
sive production of full length PfVIT. As shown in Fig. 1, growth of test expression cultures at 25 °C for 4 h after 
addition of L-arabinose to a concentration of 0.001% w/v revealed a single band with an apparent molecular mass 
of ~32 kDa on the western blot. Increasing the L-arabinose concentration to 0.01% w/v or greater resulted in the 
appearance of a ~20 kDa band in addition to the ~32 kDa band. Although the apparent mass of the ~32 kDa band 
is about 10% smaller than the theoretical 34.9 kDa mass of the full length protein construct, anomalous migration 
on SDS-PAGE is a phenomenon commonly observed with membrane proteins18. There was no detectable expres-
sion of target protein in the absence of L-arabinose.
Mass spectrometry analyses of the ~32 kDa and ~20 kDa bands excised from a Coomassie-stained SDS-PAGE 
gel confirmed that the ~32 kDa band corresponded to full length PfVIT construct, whereas the ~20 kDa band 
corresponded to a product that likely arose due to in vivo proteolytic attack at the hydrophilic loop region that 
Figure 1. Western blot analysis of heterologous overexpression of recombinant P. falciparum PfVIT in E. 
coli.  80 μg of total protein from DDM-detergent solubilised membranes of E. coli LMG194 that overexpressed 
target protein from pBAD/Myc-His vector that contained synthetic, codon-optimised PfVIT coding sequence 
was loaded onto each lane of the gel. Hexahistidine-tagged PfVIT was detected by HisProbe-horseradish 
peroxidase. Cultures were grown at 25 °C for 4 h post addition of the indicated concentrations of L-arabinose 
inducer. Only an L-arabinose concentration of 0.001% w/v resulted in exclusive overproduction of full length 
recombinant PfVIT correctly targeted to the E. coli inner membrane. Upper arrow indicates ~32 kDa full length 
recombinant protein. Lower arrow indicates ~20 kDa truncated PfVIT.
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connects predicted transmembrane spanning helices 2 and 3 of the PfVIT protein (Supplementary Fig. S2b). 
Having established heterologous expression conditions that overproduced PfVIT and targeted it to the E. coli 
inner membrane, conditions were scaled-up to enable purification of recombinant transporter in the quantities 
required for downstream biochemical analysis.
Heterologous expression of PfVIT in E. coli results in a phenotype with increased resistance to 
iron-mediated cell death. Deletion of the gene encoding the vacuolar iron transporter CCC1 in the yeast 
Saccharomyces cerevisiae results in a mutant susceptible to iron toxicity due to an inability to transport excess 
intracellular iron into the vacuole13. The iron-sensitive phenotype of the Δccc1 mutant can, however, be rescued 
by complementation with a plasmid that encodes PfVIT17 or homologous plant VIT proteins10,12,19. We hypothe-
sised that transformation of E. coli cells with a plasmid that encoded PfVIT would confer the bacterial cells with 
greater resistance to iron-mediated cell death if the expressed protein was functional in the bacterial inner mem-
brane. We initially performed qualitative assays in solid media that contained various concentrations of added 
Fe2+ to assess the effects of heterologous expression of PfVIT from pBAD/Myc-His A vector on E. coli growth 
phenotype (Fig. 2). On LB agar plates that contained either no added Fe2+ or Fe2+ added to 3 mM, control cells 
that harboured empty vector exhibited similar growth to those that expressed PfVIT (Fig. 2a). However, when the 
concentration of Fe2+ was increased to 5 mM, PfVIT-expressing cells grew better than the controls.
The ability of PfVIT to confer E. coli with greater tolerance to Fe2+ was quantitated using survival assays 
that employed colony-forming unit (cfu) counts. The quantitative data (Fig. 2b), which assessed the viability of 
cells cultured in Fe2+ -containing liquid LB media, corroborated the results of the qualitative growth assays. As 
expected for cells under stress of recombinant protein overproduction, the cfu count of PfVIT-expressing cells 
(109 cfu/ml) grown in liquid medium that contained no additional Fe2+ was 10-fold lower than that of cells which 
harboured empty vector (1010 cfu/ml). To assess the viability of cells grown in media that contained added Fe2+, 
subsequent cfu counts were expressed as a percentage of these controls. As shown in Fig. 2b, at external Fe2+ 
concentrations of 1 mM and 3 mM, the viability of PfVIT-expressing cells and those that harboured empty vec-
tor did not differ significantly and the growth of both strains was actually enhanced compared to the controls. 
Enhancement of cell survival at these Fe2+ concentrations was likely due to the immediate availability to the cells 
of ferrous iron for use in respiratory chain proteins and as an electron donor, and both the bacterial strains were 
therefore able to take advantage of these non-limiting, yet non-lethal, concentrations of ferrous iron to promote 
growth. However, when the concentration of exogenous ferrous iron was increased to 5 mM, the effect of heterol-
ogous expression of PfVIT became readily apparent; in contrast to the results of the cell survival assays performed 
at the lower Fe2+ concentrations, at 5 mM Fe2+ the viability of cells that contained empty vector was significantly 
impaired (P = 0.0063) compared to that of PfVIT-expressing cells. Neither transformant was capable of survival 
in media that contained Fe2+ at 10 mM.
The quantitative assays were repeated to assess if heterologous expression of PfVIT could render E. coli resist-
ant to the cytotoxic effects of other divalent transition metal cations (Mn2+, Zn2+, Ni2+ and Co2+) and also to pro-
vide some insight into the potential substrate specificity of PfVIT. The assays revealed that PfVIT did not confer 
tolerance to those transition metals at the concentrations tested (Supplementary Fig. S4).
To determine whether the enhanced survival of PfVIT-expressing cells grown in Fe2+− containing medium 
was due to depletion of intracellular iron by PfVIT transport activity, total iron content of cells was measured 
using inductively coupled plasma-mass spectrometry (ICP-MS)20. Following 30-min exposure to FeSO4, cells 
that expressed PfVIT had a significant reduction in total iron content compared to cells that did not express the 
protein; at 1 mM Fe2+ the reduction in cellular iron content was ~39% (P = 0.0092), and at Fe2+ concentrations of 
3 mM and 5 mM in the medium, iron content was reduced by ~29% (P = 0.0197) and ~24% (P = 0.0003), respec-
tively (Fig. 2c).
Taken together, the metal sensitivity and ICP-MS data are supportive of the notion that recombinant PfVIT 
overexpressed in E. coli is functional in the bacterial inner membrane and can confer the bacterium with increased 
tolerance to ferrous iron. Furthermore, the experiments demonstrated that Plasmodium-specific factors, such as 
phosphorylation by parasite kinases, were not required for this PfVIT function in the bacterial system.
PfVIT mediates Fe2+/H+exchange in inverted vesicles. The survival assay and ICP-MS data implied 
that a PfVIT-mediated efflux activity transported excess cytoplasmic Fe2+ out of the bacterial cell. To test if PfVIT 
could mediate such transport via exchange of ferrous iron for protons, we measured the changes in luminal 
pH of PfVIT-enriched inverted membrane vesicles upon addition of the divalent metal cation substrate. This 
was achieved by monitoring the changes in fluorescence of a pH-sensitive probe, acridine orange, encapsulated 
within the vesicles. To inhibit oxidation and precipitation of the ferrous iron substrate, the vesicle mixture was 
maintained under constant nitrogen flush for the duration of the assay. Inverted vesicles prepared from cells that 
overproduced glycerol 3-phosphate/Pi antiporter GlpT (an E. coli membrane protein that does not bind or trans-
port divalent metal cations21) from pBAD vector were used as a control. Expression levels of PfVIT and GlpT in 
their respective vesicles were similar, as assessed by western blot analysis (Supplementary Fig. S5a).
As shown in Fig. 3, addition of D-lactate to energise the vesicles resulted in quenching of the acridine orange 
fluorescence signal as protons were pumped by respiratory chain proteins into the vesicular lumen to generate a 
pH gradient (Δ pH; acid inside) across the vesicle membrane. Due to the oxygen-depleted conditions employed 
in the system to prevent oxidation and subsequent precipitation of the ferrous iron substrate, the scale of the 
respiration-induced acridine orange fluorescence quench in these assays was about an order of magnitude smaller 
than that observed in the assays that tested for transport of other metal cations, and which did not require anaer-
obic conditions (compare traces in Fig. 3 with those in Supplementary Fig. S5b–d). It should be noted that, in the 
oxygen-depleted system, carbonyl cyanide 3-chlorophenylhydrazone (CCCP) could not be used to dissipate the 
proton electrochemical gradient. This was due to a reaction that caused a precipitate to form and interfere with the 
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spectroscopic measurements. Instead, Triton X-100 detergent was added to the mixture at the time indicated to 
disrupt the vesicle membranes and dissipate the Δ pH.
While vesicles prepared from cells that overexpressed PfVIT were clearly Fe2+ transport-active (as revealed 
by a slow dequench of the initial fluorescence signal upon addition of Fe2+ to 5 μ M), control vesicles exhibited no 
transport activity (Fig. 3a). When the concentration of Fe2+ used to initiate transport was increased 10-fold to 
50 μ M, the negative control vesicles exhibited a small fluorescence dequench which could be attributed to activity 
of low-affinity, chromosomally encoded transporters capable of Fe2+ transport (Fig. 3b; left panel). In contrast, 
addition of 50 μ M Fe2+ to PfVIT-enriched vesicles resulted in a much larger and instantaneous dequench of the 
Figure 2. E. coli cells expressing PfVIT are more resistant to iron-mediated cell death and have reduced 
total iron content. (a) Growth of E. coli LMG194 cells transformed with pBAD vector encoding PfVIT on solid 
LB medium that contained Fe2+ (added in the form of ammonium FeSO4 in the presence of 2 mM ascorbic 
acid) at the concentrations indicated, and 0.001% w/v L-arabinose to induce expression of the protein. Cells 
transformed with empty pBAD vector were used as controls. Aliquots of 2 μ l of a logarithmic dilution series of 
cells grown to an initial OD600 of 1.0 were spotted onto the solid medium and the plates incubated for 24 h at 
30 °C. (b) The effect of functional expression of PfVIT on survival of E. coli LMG194 cells in liquid LB medium 
that contained Fe2+ at the concentrations indicated, and L-arabinose to induce expression of the protein. Cells 
transformed with empty pBAD vector provided controls. After 16 h incubation with shaking at 25 °C, cell 
viability was determined by performing colony forming unit (cfu) counts of cells plated onto solid LB medium. 
The cfu counts were normalised to those of cultures that were plated onto medium that contained no additional 
Fe2+. (c) E. coli LMG194 cells that overproduced recombinant PfVIT had reduced iron content compared to 
cells that harboured empty vector. Cells were exposed to the indicated concentrations of ferrous iron for 30 min 
prior to determination of total cellular iron content by ICP-MS. Data in (b) and (c) are the mean ± s.d. of three 
separate measurements, and significance was determined by unpaired, two-tailed Student’s t-test; *P < 0.05, 
**P < 0.01, ***P < 0.001.
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acridine orange fluorescence (Fig. 3b; right panel). These results are in accord with a proton-driven Fe2+/H+ 
antiport function for PfVIT.
To test substrate specificity of PfVIT, the effects of addition of Mn2+, Ni2+ or Co2+ to the transport assay 
system were assessed (Supplementary Fig. S5b–d). Addition of Ni2+ or Co2+ to a final concentration of 5 mM 
(a concentration 1000-fold greater than the 5 μ M concentration of Fe2+ that stimulated PfVIT-mediated trans-
port) had no effect on the acridine orange fluorescence signal of PfVIT-containing vesicles. Addition of 5 mM 
Mn2+ to PfVIT-containing vesicles, however, did result in detectable transport activity (Supplementary Fig. S5b). 
Although this indicates that PfVIT possesses capacity to transport Mn2+ when the metal is present at relatively 
high and non-physiological concentrations, consideration of the results of the cell survival data presented in 
Supplementary Fig. S4a (in which there was no significant effect of PfVIT on cell survival at any of the Mn2+ 
concentrations tested) suggests that this transport is not biologically relevant and probably represents a low affin-
ity interaction between PfVIT and Mn2+ in the inverted vesicle system. We therefore believe that our data are 
supportive of the contention by Slavic et al.17 that PfVIT is selective for Fe2+. We were unable to test if PfVIT 
possessed capacity to mediate proton-driven exchange of Zn2+, Cu2+, Mg2+ or Ca2+ in the same system due to 
interference from the activity of other transporters of these metals in the bacterial membrane22–25.
Recombinant PfVIT purifies as a monomer. Recombinant PfVIT was purified to homogeneity using a 
two-column chromatography protocol. DDM-solubilised membranes were incubated with Co2+-affinity resin 
to bind the recombinant His-tagged protein. Elution of bound PfVIT by on-column thrombin cleavage typically 
yielded about 1.5 mg to 2 mg of semi-purified protein (from 12 l of culture) that migrated as a single fuzzy band 
with an apparent mass of ~30 kDa on Coomassie-stained SDS-PAGE (Supplementary Fig. S6). The protein was 
subsequently purified further by size-exclusion chromatography.
Tag-cleaved PfVIT eluted as a single major peak at a volume of 13.8 ml from the size-exclusion column 
(Fig. 4a). Two other integral membrane proteins that we work with (and that are monomeric) – the E. coli GlpT 
(53 kDa)21 and multidrug efflux protein MdtM (45 kDa)26 - eluted at 11.6 ml and 12.0 ml, respectively on the same 
column. Therefore, an elution volume of 13.8 ml is consistent with a monomeric PfVIT-detergent-lipid complex. 
Analysis of the peak fractions by Coomassie-stained SDS-PAGE revealed the protein to be > 95% pure (Fig. 4b) 
and yields of pure PfVIT recovered from the size-exclusion column were typically in the ~0.5 mg range. MALDI 
TOF/TOF mass spectrometry analysis of purified, trypsin-digested protein confirmed that the band observed on 
SDS-PAGE was full length PfVIT.
Figure 3. PfVIT-dependent Fe2+/H+ exchange in inverted vesicles. Measurements were performed by 
monitoring the fluorescence dequench of acridine orange upon addition of Fe2+ to inverted vesicles prepared 
from E. coli LMG194 cells that overproduced recombinant PfVIT (right traces) or, as a control, GlpT (left 
traces). Respiration-dependent generation of a transmembrane electrochemical gradient (acid inside) was 
established by addition of lactate as indicated. Once the quench of the fluorescent indicator reached a steady 
state, Fe2+ substrate was added to a final concentration of (a) 5 μ M or (b) 50 μ M. The pH gradient was dissipated 
by addition of Triton X-100 detergent at the time indicated. Traces are representative of experiments performed 
in triplicate on at least two separate preparations of vesicles. Fluorescence intensity was measured in counts per 
second (cps).
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Purified PfVIT in detergent solution binds Fe2+ substrate with low micromolar affinity. PfVIT 
contains a single tryptophan and eleven tyrosine residues (Supplementary Fig. S2a). We hypothesised that bind-
ing of substrate to PfVIT might quench the intrinsic fluorescence of one or more of these residues and provide a 
method not only to judge the functional integrity of the protein after purification but also to assess the affinity of 
PfVIT for substrate. The apparent affinity of PfVIT for substrate was determined from the concentration of Fe2+ 
that produced half-maximum quenching of the protein fluorescence.
The fluorescence emission spectrum (between 320 nm and 400 nm) of purified PfVIT in 0.01% w/v FC-12 
detergent solution at pH 6.0 revealed maximal fluorescence emission to be centred at a wavelength of 337 nm 
when the protein was excited with light at 280 nm (Fig. 5a). Addition of Fe2+ to the protein solution induced a 
concentration-dependent quenching of the fluorescence emission without shifting the λ max. The apparent disso-
ciation constant (Kdapp) for Fe2+ binding to the transporter was determined as 1.9 ± 0.4 μ M (mean ± s.d) (Fig. 5b), 
indicating that purified PfVIT in FC-12 detergent solution retained substrate-binding capability and that our 
purification protocol resulted in functional protein.
As a control, we tested for binding of Zn2+ (a divalent metal cation that is not a substrate of PfVIT17 ) to the 
purified transporter. In contrast to the concentration-dependent fluorescence quenching observed when Fe2+ was 
titrated into the system and bound to the protein, addition of Zn2+ resulted in a small, nonspecific effect on the 
fluorescence emission at each concentration tested (Fig. 5b).
Discussion
Vacuolar iron transport proteins play a vital role in compartmentalisation of labile Fe2+ in non-animal cells and 
thereby contribute to iron homeostasis in those systems. In yeast cells vacuolar uptake of Fe2+ is mediated by 
CCC113, in plants by the CCC1 homologue vacuolar iron transporter 1 (VIT1)10,19 and in malaria-causing P. 
falciparum by the vacuolar iron transporter homologue PfVIT17. Despite the importance of VIT proteins to iron 
Figure 4. Purification of PfVIT by size-exclusion chromatography. (a) PfVIT was detected at 280 nm as 
a single major peak that eluted at 13.8 ml. The arrows correspond to peak fractions collected for analysis by 
SDS-PAGE. (b) Coomassie-stained SDS-PAGE analysis of peak PfVIT protein fractions from gel filtration 
chromatography. 10 μ g of protein was loaded onto each lane.
Figure 5. Substrate-binding affinity of purified PfVIT as measured by intrinsic protein fluorescence 
quenching. (a) Baseline-corrected fluorescence emission spectra of purified, detergent-solubilized PfVIT upon 
excitation at 280 nm. Fluorescence was measured at pH 6.0 in the absence or presence of the sulphate salt of Fe2+ 
at different concentrations (beginning at the top of the traces: 0, 0.5, 5, 20, 50 and 100 μ M final concentration).  
(b) Substrate-binding affinity curve of Fe2+ binding (filled symbols) to purified PfVIT in FC-12 detergent 
solution. A control was provided by titration of Zn2+ (empty symbols) – a divalent metal cation that is not 
transported by PfVIT – into the protein solution. Data points and error bars represent the mean ± s.d. of three 
measurements.
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7Scientific RepoRts | 7:42850 | DOI: 10.1038/srep42850
sequestration in many biological systems, little is understood of their mechanism of transport. Furthermore, 
although Plasmodium membrane proteins represent attractive potential drug targets, detailed investigation of 
their biochemical and biophysical properties has been hindered by lack of a source of isolated and functional 
recombinant proteins from the parasite27,28, exceptions being chloroquine resistance transporter PfCRT29, 
multi-drug resistance transporter PfMDR130 and copper transport protein Ctr131.
Due to financial and temporal factors, ease of use and genetic manipulation, E. coli is still a favoured host for 
heterologous expression of recombinant proteins. However, eukaryotic membrane proteins are often refractory 
to heterologous overexpression in E. coli and, in the case of P. falciparum proteins, rare codon usage and genome 
AT-richness can affect recombinant expression32. Use of a codon-optimised, synthetic gene that encoded PfVIT 
ligated into a vector containing the arabinose PBAD promoter, combined with systematic identification of appro-
priate culture conditions, enabled heterologous overproduction of functional PfVIT in E. coli. This approach may 
have wider application and enable functional overexpression of transporters from other plasmodial subcellular 
membranes.
Functional overexpression of PfVIT in the E. coli inner membrane permitted investigation of the substrate 
specificity profile of the transporter using a combination of assays of cell survival in the presence of externally 
added divalent metal cations and vesicular transport assays. E. coli cells that expressed PfVIT were rendered more 
tolerant towards the cytotoxic effects of Fe2+ but not the other first row transition metal ions Mn2+, Zn2+, Co2+ 
or Ni2+. This implies that PfVIT can distinguish between Fe2+ and other divalent metal cations. The origin of 
this metal selectivity is currently not understood, and whether PfVIT possesses one or more Fe2+-binding sites, 
and the identity of the coordinating ligands is unknown. However, as the ionic radii of all the first row transition 
metals tested are in a similar range, the observation that not all of them are transported by the protein suggests 
selectivity is not achieved solely on the basis of size. We therefore speculate that coordination number and geom-
etry of the metal ion substrate are likely discriminating factors. A detailed description of substrate selectivity 
and binding by PfVIT will have to await the availability of high-resolution structural information on the protein 
bound to its metal cation substrate.
A previous study performed on PfVIT in a yeast system provided strong evidence for a ferrous iron transport 
function for the transporter17; as we have shown, the ability of heterologous expression of recombinant PfVIT 
in E. coli to confer protection against the cytotoxic effects of excess Fe2+ is consistent with such a function. The 
results of our vesicular transport assays and ICP-MS analysis provide additional persuasive evidence that, in the 
E. coli membrane environment, PfVIT functions as a Fe2+/H+transporter that utilises the electrochemical trans-
membrane gradient to catalyse a proton-driven antiport. Furthermore, the binding data obtained from purified 
PfVIT in detergent solution are consistent with the notion of PfVIT as a relatively low affinity (but high capacity) 
Fe2+ transporter17.
Protein phosphorylation plays an important regulatory role in the life cycle of the malaria parasite33 and, 
interestingly, PfVIT is postulated to possess four phospho-acceptor sites located on the N-terminal tail and the 
putative hydrophilic loop that connects TM2 and TM3 at amino acid residues S21, S122, S140 and T15033,34. 
This suggests phosphorylation/dephosphorylation of these residues as a possible regulatory mechanism for 
PfVIT-mediated transport. Indeed, other transporter proteins such as the biogenic monoamine transporters in 
mammalian brain utilise phosphorylation/dephosphorylation of the protein to regulate transport direction and 
activity35. Notably, we have demonstrated that PfVIT is functional in the E. coli membrane; this implies that 
Plasmodium-specific kinases/phosphatases are not required for the PfVIT transport function in the bacterial 
system although phosphorylation of the transporter might still be important in the malaria parasite for regulating 
function. Further interrogation of the functional and/or structural role of phosphorylation/dephosphorylation of 
PfVIT is now enabled by availability of purified recombinant protein.
The work presented here opens the door for a better understanding of the function and mechanism of a VIT 
family representative and, ultimately, it is hoped it will aid a fuller understanding of iron homeostasis in an impor-
tant human pathogen.
Methods
All growth media, antibiotics and reagents were purchased from Sigma-Aldrich (UK) unless stated otherwise.
Synthesis and cloning of the PfVIT coding sequence. The 822 bp sequence (PlasmoDB gene ID: 
PF3D7_1223700) encoding the 273 amino acid residue PfVIT transporter from Plasmodium falciparum 3D7 was 
codon-optimised for expression in Escherichia coli (Supplementary Fig. S2) and synthesised using a commercially 
available service (GenScript, USA). Nco1 and EcoR1 restriction sites were introduced into the 5′ and 3′ -ends of 
the synthetic DNA, respectively, and the optimised coding sequence was ligated into the multiple cloning site of a 
modified pBAD/Myc-His A expression vector (Invitrogen, UK) in frame with the plasmid-borne C-terminal His6 
affinity tag to give a construct of 307 amino acid residues and molecular mass of 34.9 kDa. A thrombin-specific 
proteolysis site (LVPRGS) permitted subsequent cleavage of the Myc-His tag. The fidelity of the construct was 
verified by DNA sequence analysis.
Protein overproduction. The plasmid construct was transformed into chemically competent E. coli 
LMG194 cells36 and an overnight culture grown from a single colony of freshly transformed cells was diluted 
100-fold into twelve 5 l flasks, each containing 1 l of Luria Bertani (LB) broth supplemented with 100 μ g ml−1 
carbenicillin (Carbenicillin Direct, UK). These cultures were grown at 32 °C with 220 rpm shaking till the OD600 
was 0.4, then the temperature was downshifted to 25 °C. At OD600 of 0.7 expression of PfVIT was induced by 
addition of 0.001% w/v L-(+ ) arabinose (Melford Laboratories Ltd., UK). Cells were grown for a further 4 h prior 
to harvesting.
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SDS-PAGE and western blot analysis. Expression levels of recombinant protein were analysed by west-
ern blot of DDM-detergent solubilised E. coli cell membranes. Solubilised protein samples of 80 μ g (as determined 
by BCA assay) were loaded onto a bis-Tris gel of 15% acrylamide and resolved via SDS-PAGE before transfer to 
nitrocellulose membrane. The hexahistidine-tagged proteins were detected using HisProbe-HRP and SuperSignal 
West Pico Chemiluminescent Substrate (Thermo Scientific, UK) according to the manufacturer’s instructions.
Metal sensitivity assays. Cultures of E. coli LMG194 transformed with either empty pBAD vector or pBAD 
vector that encoded PfVIT were grown from single bacterial colonies in LB medium supplemented with 100 μ g ml−1 
carbenicillin at 32 °C with shaking for 16 h then diluted 100-fold into fresh, antibiotic-containing LB broth. At 
OD600 of 0.4 the temperature was decreased to 25 °C and the cultures incubated until OD600 of 0.7. Expression of 
PfVIT was induced by addition of 0.001% w/v L-(+ ) arabinose and the cells grown for a further 2 h prior to use 
in qualitative assays on solid LB medium. For these assays, 2 μ l aliquots from a 10−3 to 10−6 logarithmic dilution 
series of cultures that had OD600 adjusted to 1.0 were spotted onto LB agar plates containing 100 μ g ml−1 carbeni-
cillin and 0.001% w/v L-(+ ) arabinose to which 2 mM ascorbic acid and Fe2+ in the form of ammonium iron (II) 
sulphate at the stated concentrations were added. Plates were incubated for 24 h at 30 °C prior to imaging.
Quantitative assays of metal sensitivity were performed by counting the number of viable E. coli colonies after 
growth in liquid LB medium containing Fe2+, Mn2+, Zn2+, Co2+or Ni2+ at concentrations from 0 to 10 mM. The 
metal ions were provided in the form of their chloride salts, except for Fe2+ which was supplied to the medium as 
ammonium iron (II) sulphate in the presence of 2 mM ascorbic acid. Overnight cultures of E. coli LMG194 trans-
formed with either empty pBAD vector or vector that encoded PfVIT were diluted 100-fold into LB broth con-
taining 100 μ g ml−1 carbenicillin and incubated at 32 °C with shaking until OD600 achieved 0.4. The temperature 
was then decreased to 25 °C and the cultures grown to OD600 of 0.7. Recombinant protein expression was induced 
for 2 h by addition of 0.001% (w/v) L-(+ ) arabinose. Subsequently, 100 μ l of culture was diluted into 10 ml of LB 
broth supplemented with antibiotic, 0.001% (w/v) L-(+ ) arabinose, 2 mM ascorbate and the appropriate metal 
ion concentration in 14 ml polypropylene BD Falcon tubes (Corning, Mexico). The tubes were incubated for 16 h 
at 25 °C with gentle shaking. 100 μ l aliquots were taken to perform serial dilutions in sterile Maximum Recovery 
Diluent (MRD). Diluted samples were then plated onto LB agar and the plates incubated overnight at 30 °C prior 
to performing colony counts.
Quantitation of cellular iron content by ICP-MS. Quantitation of cellular iron content was performed 
using a method based on that described by Frawley et al.37. E. coli LMG194 cells transformed with either empty 
pBAD vector or pBAD vector that encoded PfVIT were grown in liquid LB medium as described above. After 2 h 
of induction, 5 ml aliquots of cells were pipetted into BD Falcon tubes containing LB broth, 2 mM ascorbate and 
ammonium iron (II) sulphate at the stated concentrations, and incubated for a further 30 min at 25 °C with gentle 
shaking. Cells were pelleted by centrifugation, washed twice with 10 ml MRD containing 1 mM EDTA and once 
with 1 ml of the same buffer, followed by centrifugation to remove the supernatant. The pelleted cells were air 
dried for 24 h then weighed. To prepare the samples for ICP-MS, cells were suspended in 1 ml of trace metal grade 
concentrated nitric acid (ROMIL Ltd., UK) and incubated at 80 °C for 45 min. Samples were centrifuged at high 
speed for 15 min, and 0.5 ml from each sample was transferred into 15 ml tube. The nitric acid solution was then 
diluted 1:10 by adding 4.5 ml MilliQ purified water. ICP-MS analysis was performed on an Agilent 7900 ICP-MS 
instrument by the Spectroscopy Group, Analytical Services, Almac, UK.
Protein purification. PfVIT was purified using a protocol based on one described previously38. Harvested 
cells were resuspended in ice cold TBS (50 mM Tris-HCl, 100 mM NaCl, pH 7.5) and collected by centrifuga-
tion. All subsequent steps were performed at 4 °C. Cell pellet was resuspended in TBS buffer containing protease 
inhibitor cocktail (cOmplete™ , Roche, UK) and 0.05% w/v β -mercaptoethanol to a final concentration of 0.2 g 
cells per ml. Resuspended cells were incubated under gentle agitation with 0.5 mg ml−1 lysozyme in presence of 
1 mM EDTA for 30 min prior to treatment with 0.03 mg ml−1 DNase and 5 mM MgCl2. Complete cell breakage 
was achieved by three passages of the sample through a pre-chilled French pressure cell at 16,000 psi. Unbroken 
cells were removed by centrifugation at 20,000× g for 30 min, and the membrane pellet collected by ultracen-
trifugation. Isolated membranes were resuspended in solubilisation buffer (50 mM Tris-HCl pH 7.5, 300 mM 
NaCl, 10 mM imidazole) to a final concentration of 100 mg ml−1 and solubilised by incubation with 1.0% w/v 
dodecyl-β -D-maltopyranoside (DDM; Melford Laboratories Ltd., UK) for 1 h under gentle stirring. Solubilised 
membrane proteins were loaded onto an Econo-column (Bio-Rad Laboratories, UK) containing 0.5 ml of HisPur 
cobalt affinity resin (ThermoFisher Scientific, UK) and unbound protein was allowed to flow through under 
gravity. The column was then washed with 20 column volumes (CVs) of wash buffer (50 mM Tris-HCl pH 8.0, 
300 mM NaCl, 10% v/v glycerol, 0.1% w/v DDM) containing 10 mM imidazole to remove non-specifically bound 
contaminants then incubated with ATP dissociation buffer (wash buffer containing 10 mM MgCl2, 5 mM ATP, 
150 mM KCl) for 1 h to remove contaminating chaperonins. The resin was then washed with 20 CVs wash buffer 
supplemented with 30 mM imidazole prior to detergent exchange with 10 CVs of wash buffer containing 1% 
w/v Fos-Choline-12 (FC-12; Anatrace, UK). Subsequent to an additional wash step with buffer containing 0.1% 
w/v FC-12 the PfVIT target protein was cleaved from the column by incubation with 6 NIH units of thrombin 
(Novagen, UK). The volume of eluted protein was reduced to 1 ml using a 50 kDa MWCO centrifugal concen-
trator (Millipore, UK) then loaded onto a Superdex 200 10/300 GL gel filtration column (GE Healthcare, UK) 
equilibrated with 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 5% v/v glycerol, 1 mM DTT, 0.1% 
w/v FC-12 and connected to an ÅKTA FPLC system. The chromatography run was performed at a flow-rate of 
0.4 ml min−1 and protein was monitored by measuring absorbance at 280 nm.
www.nature.com/scientificreports/
9Scientific RepoRts | 7:42850 | DOI: 10.1038/srep42850
Protein quantitation. Protein was quantified by BCA assay (Thermo Scientific Pierce, USA) in accordance 
with the manufacturer’s instructions.
Mass spectrometric analysis. Coomassie-stained SDS-PAGE gel bands were excised and cut into 1 mm 
cubes. These were then subjected to in-gel digestion, using a ProGest Investigator in-gel digestion robot (Digilab) 
using standard protocols39. Briefly, the gel cubes were destained by washing with acetonitrile and subjected to 
reduction and alkylation before digestion with trypsin at 37 °C. The peptides were extracted with 10% formic 
acid. For MALDI TOF/TOF analysis the digest solution (0.5 μ L) was applied to the MALDI target along with 
alpha-cyano-4-hydroxycinnamic acid matrix (0.5 μ L, 10 mg/mL in 50:50 acetonitrile:0.1% TFA) and allowed to 
dry. MALDI MS was acquired using a 4800 MALDI TOF/TOF Analyser (ABSciex) equipped with a Nd:YAG 
355 nm laser and calibrated using a mixture of peptides. The most intense peptides (up to 15) were selected for 
MSMS analysis and the MS data analysed, using GPS Explorer (ABSciex) to interface with the Mascot 2.4 search 
engine (Matrix Science) and the MSMS data using Mascot 2.4 directly. Swiss-Prot (Dec 2012) or NCBInr (Aug 
2013) databases were interrogated. No species restriction was applied. The data were searched with tolerances of 
100 ppm for the precursor ions and 0.5 Da for the fragment ions, trypsin as the cleavage enzyme, assuming up to 
one missed cleavage, carbamidomethyl modification of cysteines as a fixed modification and methionine oxida-
tion selected as a variable modification.
Vesicular transport assays. All transport assays were performed at pH 7.2 on inverted vesicles generated 
from E. coli LMG194 cells that overexpressed recombinant PfVIT or, as a control, GlpT. Assays designed to detect 
changes in pH due to PfVIT-mediated Fe2+/H+ exchange utilised the fluorescent indicator acridine orange and 
were performed following a protocol described previously40.
For measurements of ferrous iron transport, Fe2+ substrate was provided in the form of its sulphate salt to final 
concentrations of 5 μ M and 50 μ M. To prevent oxidation and precipitation of the ferrous iron substrate in these 
experiments, all assay components were bubbled with nitrogen and the cuvette compartment of the fluorometer 
was maintained under constant nitrogen flush for the duration of the assay. In all transport assays the vesicles 
were energised by addition of 2 mM sodium lactate. In assays that tested for PfVIT-mediated transport of Fe2+ the 
proton electrochemical gradient was collapsed by addition of Triton X-100 to 0.07% (v/v) to disrupt the vesicles. 
In assays that tested for PfVIT-mediated transport of other divalent metal cations the proton electrochemical 
gradient was collapsed by addition of 100 μ M CCCP.
Substrate binding activity. Substrate-binding affinity of purified recombinant PfVIT for divalent metal 
ions in detergent solution was determined by intrinsic protein fluorescence quenching studies. Fluorescence 
experiments were performed at an excitation wavelength of 280 nm in a Fluoromax-4 fluorometer (Horiba UK 
Ltd) fitted with a thermostatically controlled cuvette holder. Purified PfVIT at a final concentration of 0.3 μ M in 
FC-12 detergent solution (50 mM Bis-Tris pH 6.0, 100 mM NaCl, 5% v/v glycerol, 0.01% w/v FC-12) was titrated 
with the sulphate salt of Fe2+ until maximal fluorescence quenching at the emission maximum of 337 nm was 
achieved. All buffers were bubbled with nitrogen to remove dissolved oxygen prior to measurements of fluo-
rescence and the cuvette compartment of the fluorometer was maintained under constant nitrogen flush for the 
duration of each experiment. As a control, the protein solution was titrated with the chloride salt of Zn2+. All 
measurements were performed in triplicate at 25 °C. The data underwent nonlinear regression analysis to calcu-
late the apparent dissociation constant, Kdapp, for binding.
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